Nicoleta Gherghel-Pavăl

Nicoleta Gherghel-Pavăl

Auto-generated profile, based on publicly available information

Nicoleta Gherghel-Pavăl

Romanian Association for Autoimmune Encephalitis, Cluj-Napoca, Romania

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2024 in Clinical Psychopharmacology and Neuroscience
Verified
Journal Article
Open access
PDF file
DPDenis Pavăl
Denis Pavăl
NGNicoleta Gherghel-Pavăl
Nicoleta Gherghel-Pavăl
OCOctavia Oana Capatina
Octavia Oana Capatina
ASADINA STAN
ADINA STAN
Lajos-Zsolt RadulyLajos-Zsolt Raduly
Lajos-Zsolt Raduly
IMIoana Valentina Micluţia
Ioana Valentina Micluţia
Denis Pavăl, Nicoleta Gherghel-Pavăl, Octavia Oana Căpățînă, Adina Stan, Lajos Raduly, Liviuța Budișan, Ioana Valentina Micluția. Clin Psychopharmacol Neurosci 2024;22:520-30. https://doi.org/10.9758/cpn.24.1164

25 March 2025 in Health Science Reports
Verified
Journal Article
Open access
NGNicoleta Gherghel‐Pavăl
Nicoleta Gherghel‐Pavăl
DPDenis Pavăl
Denis Pavăl
ASAdina D. Stan
Adina D. Stan
OOOlga H. Orășan
Olga H. Orășan
ASAdela V. Sitar‐Tăut
Adela V. Sitar‐Tăut
ACAngela Cozma
Angela Cozma
Background and Aims: While multiple sclerosis (MS) is primarily considered a neurological disorder, mounting evidence suggests a strong association with cardiovascular diseases (CVDs), impacting both disease progression and patient outcomes. This paper aims to raise awareness of this disease association while promoting a clinical‐oriented, multidisciplinary approach that can provide long‐term benefits for these patients.Methods: A comprehensive literature review was conducted to gather up‐to‐date evidence concerning the incidence and type of CVDs associated with MS, the mechanisms underlying this disease association, as well as the impact on MS progression. Based on this evidence, a neurocardiological approach to MS in clinical practice was proposed.Results: Past and present research agree on the high rates of arterial hypertension, metabolic syndrome, stroke, and myocardial infarction in people with MS. However, other prevalent comorbidities, such as venous thromboembolism and autonomic dysfunction may be easily overlooked in clinical practice. A complex interplay between genetic predisposition, traditional risk factors, autonomic dysfunction, inflammation, and treatment‐related factors likely plays a role in promoting CVDs in MS. The impact of cardiovascular dysfunction on MS progression ranges from subclinical impairments, such as impaired axonal repairing, to overt physical disability and cognitive dysfunction. This paper proposes a neurocardiological approach to the daily clinical practice of MS patients, comprising general lifestyle measures, comorbidity screening at MS diagnosis, extensive work‐ups for progressive/active forms, and selected autonomic dysfunction screening.Conclusion: MS is a lifelong disorder that can be associated with a multitude of comorbidities, particularly cardiovascular ones. Along with increased mortality, cardiovascular pathology can adversely affect clinical and radiological‐derived MS outcomes. Thus, surveillance and preventative measures are required for this population.

1 November 2020 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
ASADINA STAN
ADINA STAN
NGNicoleta Gherghel
Nicoleta Gherghel
Dafin Fior MuresanuDafin Fior Muresanu
Dafin Fior Muresanu

4 March 2024 in International Journal of Psychiatry in Clinical Practice
Verified
Journal Article
Closed access
DPDenis Pavăl
Denis Pavăl
NGNicoleta Gherghel-Pavăl
Nicoleta Gherghel-Pavăl
OCOctavia Oana Capatina
Octavia Oana Capatina
ASADINA STAN
ADINA STAN
IMIoana Valentina Micluţia
Ioana Valentina Micluţia
Psychiatrists are often the first to be consulted in patients with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. While this disease is rare, psychiatrists need to be aware of its relevant fundamental, clinical and therapeutic aspects. We begin by reviewing the connection between anti-NMDAR encephalitis and the glutamate hypothesis of schizophrenia. Next, we focus on the profile of the patient typically afflicted with this disease. Then, we tackle the limited utility of current diagnostic criteria during the early stage of the disease. After reviewing the psychiatric features, we debate the quest for finding specific psychiatric phenotypes that could facilitate early-stage diagnosis. We conclude by discussing the treatment of psychiatric symptoms and disease outcomes. As follows, this paper presents the relevance of anti-NMDAR encephalitis for psychiatrists.